AU757806B2 - Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases - Google Patents

Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases Download PDF

Info

Publication number
AU757806B2
AU757806B2 AU36605/99A AU3660599A AU757806B2 AU 757806 B2 AU757806 B2 AU 757806B2 AU 36605/99 A AU36605/99 A AU 36605/99A AU 3660599 A AU3660599 A AU 3660599A AU 757806 B2 AU757806 B2 AU 757806B2
Authority
AU
Australia
Prior art keywords
opg
osteoprotegerin
polypeptide
lys
truncated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36605/99A
Other languages
English (en)
Other versions
AU3660599A (en
Inventor
Ildiko Sarosi
Scott Simonet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU3660599A publication Critical patent/AU3660599A/en
Application granted granted Critical
Publication of AU757806B2 publication Critical patent/AU757806B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU36605/99A 1998-04-23 1999-04-21 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases Ceased AU757806B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/064,832 US6790823B1 (en) 1998-04-23 1998-04-23 Compositions and methods for the prevention and treatment of cardiovascular diseases
US09/064832 1998-04-23
PCT/US1999/008793 WO1999053942A1 (en) 1998-04-23 1999-04-21 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases

Publications (2)

Publication Number Publication Date
AU3660599A AU3660599A (en) 1999-11-08
AU757806B2 true AU757806B2 (en) 2003-03-06

Family

ID=22058524

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36605/99A Ceased AU757806B2 (en) 1998-04-23 1999-04-21 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases

Country Status (11)

Country Link
US (1) US6790823B1 (OSRAM)
EP (1) EP1073456B1 (OSRAM)
JP (1) JP4776774B2 (OSRAM)
AT (1) ATE303817T1 (OSRAM)
AU (1) AU757806B2 (OSRAM)
CA (1) CA2325360C (OSRAM)
DE (1) DE69927147T2 (OSRAM)
DK (1) DK1073456T3 (OSRAM)
ES (1) ES2248998T3 (OSRAM)
SI (1) SI1073456T1 (OSRAM)
WO (1) WO1999053942A1 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
DE951551T1 (de) 1996-12-23 2000-09-14 Immunex Corp., Seattle Ligand für rezeptor aktivator of nf-kappa b, ligand ist mitglied der tnf superfamilie
ES2263204T5 (es) 1997-04-15 2013-10-14 Daiichi Sankyo Company, Limited Nueva proteína y proceso para producir la misma
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
RO128635A2 (ro) 1997-04-16 2013-07-30 Amgen Inc. Anticorp sau fragment al acestuia care se leagă la opgbp şi utilizarea acestuia, utilizarea unei forme solubile de odar, şi metodă de identificare a unui compus care descreşte activitatea opgbp
JP4380067B2 (ja) * 1998-04-23 2009-12-09 味の素株式会社 抗血栓活性物質及びグリコカリシンの検出法
EP2009025B1 (en) 1998-05-14 2011-07-27 Immunex Corporation Method of inhibiting osteoclast activity
AU2002253133B2 (en) * 2001-04-03 2008-02-28 Societe Des Produits Nestle S.A. Osteoprotegerin in milk
US7198798B2 (en) * 2001-05-10 2007-04-03 University Of Washington Methods and devices for promoting endothelial morphogenesis
ES2437992T3 (es) 2001-05-25 2014-01-15 Human Genome Sciences, Inc. Anticuerpos que se unen inmunoespecíficamente a los receptores de TRAIL
US8649843B2 (en) * 2001-11-24 2014-02-11 Ben A. Arnold Automated calcium scoring of the aorta
JP4761710B2 (ja) 2002-04-05 2011-08-31 アムジェン インコーポレイテッド 選択的ｏｐｇｌ経路インヒビターとしてのヒト抗ｏｐｇｌ中和抗体
US7585840B2 (en) 2002-04-10 2009-09-08 Merck Serono S.A. Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
BR0309095A (pt) * 2002-04-10 2005-02-09 Applied Research Systems Uso de osteoprotegerina para o tratamento e/ou prevenção de doença fibrótica
EP1807436B1 (en) 2004-10-25 2014-06-18 Intezyne Technologies Inc. Heterobifunctional poly(ethylene glycol) and uses thereof
EP1833958A4 (en) 2005-01-04 2009-01-14 Intezyne Technologies Inc SYNTHESIS OF HYBRID BLOCK COPOLYMERS AND USES THEREOF
US7561727B2 (en) * 2005-06-02 2009-07-14 Nordic Bioscience Imaging A/S Method of deriving a quantitative measure of a degree of calcification of an aorta
US7463758B2 (en) * 2005-06-02 2008-12-09 Nordio Bioscience A/S Method of deriving a quantitative measure of a degree of calcification of an aorta
EP2433644A1 (en) 2010-09-22 2012-03-28 IMBA-Institut für Molekulare Biotechnologie GmbH Breast cancer therapeutics
FR2970870A1 (fr) * 2011-01-31 2012-08-03 Centre Nat Rech Scient Modulation de la proliferation des cellules epitheliales de l'unite epidermo-pilo-sebacee via rank

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
AU648505B2 (en) 1989-05-19 1994-04-28 Amgen, Inc. Metalloproteinase inhibitor
US5580722A (en) * 1989-07-18 1996-12-03 Oncogene Science, Inc. Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
US6369027B1 (en) 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Also Published As

Publication number Publication date
CA2325360A1 (en) 1999-10-28
DE69927147T2 (de) 2006-01-26
ES2248998T3 (es) 2006-03-16
WO1999053942A1 (en) 1999-10-28
JP4776774B2 (ja) 2011-09-21
EP1073456B1 (en) 2005-09-07
SI1073456T1 (sl) 2005-12-31
ATE303817T1 (de) 2005-09-15
US6790823B1 (en) 2004-09-14
JP2002512199A (ja) 2002-04-23
DK1073456T3 (da) 2005-10-24
CA2325360C (en) 2008-11-04
WO1999053942A8 (en) 1999-12-02
AU3660599A (en) 1999-11-08
DE69927147D1 (de) 2005-10-13
EP1073456A1 (en) 2001-02-07

Similar Documents

Publication Publication Date Title
AU757806B2 (en) Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
CN1318588C (zh) 促骨生长素
EP0975754B2 (en) Osteoprotegerin binding proteins and their receptors
AU686232B2 (en) Activin receptors-like kinase (ALK), belonging to the TGF receptor family and/or to the BMP receptor family
PT92603B (pt) Processo de producao de factor de crescimento transformante, quimerico,beta
US20050221331A1 (en) Osteoprotegerin
US20100298229A1 (en) Osteoprotegerin
MXPA00010113A (en) Compositions and methods for the prevention and treatment of cardiovascular diseases
AU2207999A (en) Novel nucleic acid and polypeptide
AU758672B2 (en) Osteoprotegerin
TWI221482B (en) Osteoprotegerin
HK1001526B (en) Osteoprotegerin
HK1022330B (en) Osteoprotegerin binding proteins and receptors

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)